Ticker

CATX

Perspective Therapeutics, Inc.

Quiet Money · how it holds up when sold

$0.75 −4.1% since 10 NOV 2026

No Quiet Money read for CATX yet. Pro adds any actively traded US stock overnight. See Pro →

The other money · last 90 days

Short sellers are backing off and insiders are buying.

CATX in the last 90 days

Perspective Therapeutics, Inc. (CATX) short interest: FINRA’s latest report (settlement 30 OCT 2026) shows 8,974,834 shares held short, 2.5 days to cover, down 46.2% from the report before.

What the price is doing

$0.75$0.79 → $0.75 · -4% over the last month

CATX is down 4% over the last month.

$0.79 STARTNOV11 NOV 2026 — Spoor Johan M. — $37,94311 NOV 2026 — Puhlmann Markus — $4,98012 NOV 2026 — Puhlmann Markus — $29,56512 NOV 2026 — Woods Lori A — $20,04012 NOV 2026 — Williamson Robert F III — $5,27412 NOV 2026 — Williamson Robert F III — $15,63212 NOV 2026 — Morich Frank — $14,95716 NOV 2026 — Morich Frank — $14,04617 NOV 2026 — Williamson Robert F III — $20,95018 NOV 2026 — Williamson Robert F III — $12,000NOW $0.75

Insider activityBoughtSold

Politicians

None filed

Traded over the last month

Short sellers

None on file

Nothing reported in this stretch

See the numbers →

Insiders

10 reported

Traded over the last month

See the filings →

What the filings show

How the other money is read

Filings read · last 90 days

2 of 4 inputs have filings

Leaning in

Leaning outBalancedLeaning in

The disclosed money is leaning into this name, on what has actually been filed. This reads on two of its four inputs.

Not in this read: US House trades (none filed in 90 days); EU short registers (they cover European-listed companies). A missing input is left out, not counted as balanced.

Short interest
Short interest fell 61.6% — 23,352,203 to 8,974,834 shares between 31 AUG 2026 and 30 OCT 2026. See the filings →
Leans in
Insider purchases
5 insiders disclosed buying $175,386 across 8 filings.
Leans in

This summarises filings that have already been published — it is not a forecast, a rating of the company, or advice. Every figure above is listed in full further down this page, with the document it came from.

FINRA short interest

Settlement 30 OCT 2026 · shares held short

8,974,834shares held short

Days to cover

2.47

Avg daily volume

3,629,551

Since last report

-46.19%

What this number means ↓

As of 30 October 2026, 8,974,834 Perspective Therapeutics, Inc. shares were held short — the total across every reporting firm, not one fund's position. That is 7,704,879 shares fewer than the previous report, a 46.19% decrease. At the average daily volume of 3,629,551 shares, that position represents 2.47 days of trading — what the filing calls days to cover.

This is the most recent figure that exists, and it is 24 days old. FINRA collects short interest twice a month, on a settlement date, and publishes it seven business days later. So nobody has a live short-interest number for CATX — not us, and not anyone quoting one. We print the settlement date on the figure so you always know which day you are looking at.

Across the 12 reports we hold, the position has fallen from 12,615,884 shares on 15 May 2026 to 8,974,834 today, a change of 28.9%. The highest reading in that window was 23,472,935 shares on 31 July 2026.

SettlementShares shortDays to cover
30 OCT 20268,974,8342.47
15 OCT 202616,679,7138.90
30 SEPT 202616,570,6255.52
15 SEPT 202622,806,29116.85
31 AUG 202623,352,20323.64
14 AUG 202623,038,13618.22
31 JUL 202623,472,93525.65
15 JUL 202622,783,57710.01
30 JUN 202622,724,2657.28
15 JUN 202613,633,7088.99
29 MAY 202612,763,40111.31
15 MAY 202612,615,8847.96
Questions about short interest ↓
What is CATX's short interest?
8,974,834 shares, as of the 30 October 2026 settlement date. That is the figure FINRA published, unadjusted.
What percentage of the float is short?
We do not publish that, because FINRA does not publish float. The regulator reports the number of shares held short; turning it into a percentage needs a share count from somewhere else, and different sources disagree about what counts as float. We would rather give you the number that was actually filed than a percentage built on an assumption.
How current is this?
It is 24 days old, and that is as fresh as short interest gets. FINRA measures it twice a month and publishes it seven business days after the settlement date. Any site showing you a "live" short interest figure is showing you something else.
What does days to cover mean?
It is the short position divided by average daily trading volume — here, 2.47. It describes how many days of ordinary trading the position is equivalent to. It is arithmetic from the filing, not a prediction about what will happen.
Where does this come from?
FINRA's consolidated short interest file, which is public. We read it directly and store it unchanged, except that we blank the days-to-cover placeholder FINRA writes when a stock has almost no volume.

Disclosed insider buying on file

$175,386across 10 purchases

Open-market purchases only — the amount is a fact, not a verdict.

On file here

Named EU short positionsnot covered

Insider purchases10

US House transactions0

The EU registers name short sellers in European-listed companies only. FINRA’s total for this stock is above.

Latest change19 NOV 2026

Insider purchases on file

  • SEC — Form 4 insider purchase

    Williamson Robert F IIIDirector

    BOUGHTCommon Stock

    $12,000

    15,000 sh @ $0.8

    18 NOV 2026 → filed 19 NOV 2026

    Filed 1 day after the tradeSEC EDGAR · 0001193125-26-467852 →
  • SEC — Form 4 insider purchase

    Williamson Robert F IIIDirector

    BOUGHTCommon Stock

    $20,950

    25,000 sh @ $0.838

    17 NOV 2026 → filed 18 NOV 2026

    Filed 1 day after the tradeSEC EDGAR · 0001193125-26-466236 →
  • SEC — Form 4 insider purchase

    Morich FrankDirector

    BOUGHTCommon Stock

    $14,046

    15,000 sh @ $0.936

    16 NOV 2026 → filed 17 NOV 2026

    Filed 1 day after the tradeSEC EDGAR · 0001193125-26-464834 →
  • SEC — Form 4 insider purchase

    Williamson Robert F IIIDirector

    BOUGHTCommon Stock

    $5,274

    6,289 sh @ $0.839

    12 NOV 2026 → filed 16 NOV 2026

    Filed 4 days after the tradeSEC EDGAR · 0001193125-26-462220 →
  • SEC — Form 4 insider purchase

    Williamson Robert F IIIDirector

    BOUGHTCommon Stock

    $15,632

    18,609 sh @ $0.84

    12 NOV 2026 → filed 16 NOV 2026

    Filed 4 days after the tradeSEC EDGAR · 0001193125-26-462220 →
  • SEC — Form 4 insider purchase

    Morich FrankDirector

    BOUGHTCommon Stock

    $14,957

    15,000 sh @ $0.997

    12 NOV 2026 → filed 16 NOV 2026

    Filed 4 days after the tradeSEC EDGAR · 0001193125-26-462221 →
  • SEC — Form 4 insider purchase

    Woods Lori ADirector

    BOUGHTCommon Stock

    $20,040

    23,750 sh @ $0.844

    12 NOV 2026 → filed 16 NOV 2026

    Filed 4 days after the tradeSEC EDGAR · 0001193125-26-462219 →
  • SEC — Form 4 insider purchase

    Puhlmann MarkusChief Medical Officer

    BOUGHTCommon Stock

    $29,565

    35,000 sh @ $0.845

    12 NOV 2026 → filed 13 NOV 2026

    Filed 1 day after the tradeSEC EDGAR · 0001193125-26-459395 →
  • SEC — Form 4 insider purchase

    Puhlmann MarkusChief Medical Officer

    BOUGHTCommon Stock

    $4,980

    6,000 sh @ $0.83

    11 NOV 2026 → filed 13 NOV 2026

    Filed 2 days after the tradeSEC EDGAR · 0001193125-26-459395 →
  • SEC — Form 4 insider purchase

    Spoor Johan M.Director / Chief Executive Officer

    BOUGHTCommon Stock

    $37,943

    47,000 sh @ $0.807

    11 NOV 2026 → filed 12 NOV 2026

    Filed 1 day after the tradeSEC EDGAR · 0001193125-26-457093 →
What this page will never showNo buy or sell ratingsNo price targetsNo forecastsIndicators are rules-based summaries of the filingsDocuments, dates, and how long they took to become public.